An observational study in Conduction Abnormalities and Paravertebral Anesthesia, sponsored by Medical University of Gdansk. Completed at 1 site in Poland. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-04-03.
Sponsored by Medical University of Gdansk · Observational
The aim of the study is to assess the changes in electrical activity of heart atria and in atrioventricular conduction induced by anaesthetic thoracic paravertebral blockade, depending on site on which blockade was performed.
Researchers will retrospectively compare ECG recordings of patients that undergone unilateral paravertebral blockade at T3 level with 0.5% ropivacaine. The investigation will include measurement of P wave and PR interval, and subsequent statystical analysis.
Paravertebral blockade (PVB), the injection of local anaesthetic into the paravertebral space located along the vertebral column, temporarily impair the transmission in nerve fibers located in this space. Although PVB is usually used primarily with the intention of achieving block of the thoracic wall pain sensation, the paravertebral space contains not only motoric and sensory nerves, but also autonomic nerve fibers. Achieving the blockade at top four thoracic levels of paravertebral space may affect, among the others, the function of preganglionic sympathetic fibers, forming cardiac nerves, and affecting the heart function in various ways.
The assessment of electrocardiographical phenomena representing the depolarisation of the atria (P wave) and the propagation of the depolarisation by the atrioventricular node and bundle (PQ/PR interval) allows to detect the abnormalities related to proability of occurrence of supraventricular arrythmias and conduction blocks, including the life-threatening arrythmias.
The design of the study assume to retrospective re-analyse the electrocardiographical data achieved in the "Influence of Thoracic Paravertebral Block on Cardiac Repolarization" study (registred in Clinicaltrials.gov under ID NCT05822076), focused changes in heart repolarisation represented mainly by electrocardiographical QT interval and T wave dispersion.
The population of primary investigation was 60 women above 18 years of age scheduled to elective breast surgery in combined regional and general anaesthesia will be enrolled to study, divided in two groups depending of the side of operation. Participants underwent the ultrasound-guided paravertebral block with single injection of 0.5% ropivacaine (0.3 ml·kg-1, not exceeding 30 ml, based on ideal body weight in obese patients) without adjuvants. Before injection (T0) and after confirmation of sufficient sensory block area covering 1st to 4th thoracic dermatomes (T1), 12-lead electrocardiogram (ECG) will be recorded using a Holter device. First examination of sensory block distribution was performed 6 minutes after injection, with subsequent examinations if needed - every minute up to 15 minutes. No sedative premedication, general anaesthesia induction or additional medications (except of neutral saline maintaining intravenous access) were administered until completions of ECG recording. Both T0 and T1 electrocardiogram will be preceded by rest in supine position for at least 5 minutes, without any medical procedures other than monitoring.
As part of the retrospective analysis of ECG recordings obtained from the primary study, repeated measurements will be performed to assess the length of the P wave and the PQ interval at time points T0 and T1, taken as the average of three subsequent heart evolutions and measured separately for each lead. Only cases in which ECG waveform without significant artifact or interferences was obtained in at least 8 leads in both T0 and T1 will be analyzed.
From the obtained values, the P wave dispersion will be calculated (as the difference in the length of the P wave in two leads in which the average time of three evolutions was the longest and the shortest) and the PQ dispersion (as the difference in the length of the PQ interval in two leads in which the average time of three evolutions was the longest and the shortest). The obtained data will be subjected to statistical analysis taking into account the side of the body on which the intervention was performed.
980 studies on the registry are indexed under Congenital Abnormalities; 177 are open to participants now.
This study's enrollment of 60 is below the median of 153 across 446 observational studies indexed under Congenital Abnormalities.
Browse Congenital Abnormalities studies →Medical University of Gdansk is the lead sponsor of 130 studies on the registry; 46 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Women above 18 years of age, without severe systemic comorbidities, patients of University Clinical Centre of Medical University of Gdańsk qualified for elective breast surgery
Exclusion Criteria:
30 woman above 18 years of age qualified for elective breast surgery on the left side of the body
Procedure: Paravertebral block (ropivacaine) left
30 woman above 18 years of age qualified for elective breast surgery on the right side of the body
Procedure: Paravertebral block (ropivacaine) right
Paravertebral block at the level of 3rd thoracic intervertebral space on the left side. 0.5% Ropivacaine 0.3 ml·kg-1, not exceeding 30 ml, based on ideal body weight in obese patients
Paravertebral block at the level of 3rd thoracic intervertebral space on the right side. 0.5% Ropivacaine 0.3 ml·kg-1, not exceeding 30 ml, based on ideal body weight in obese patients
P wave time
difference in milliseconds of P wave time (as a mean from all measured leads) between baseline ECG \[T0\] and ECG after confirmation of sufficient area of sensory block \[T1\]
Time frame: from 6 up to 15 minutes (according to time of developement of sufficient block distribution)
P wave minimal time
difference in milliseconds of shortest P wave time (from all measured leads) between baseline ECG \[T0\] and ECG after confirmation of sufficient area of sensory block \[T1\]
Time frame: from 6 up to 15 minutes (according to time of developement of sufficient block distribution)
P wave maximal time
difference in milliseconds of longest P wave time (from all measured leads) between baseline ECG \[T0\] and ECG after confirmation of sufficient area of sensory block \[T1\]
Time frame: from 6 up to 15 minutes (according to time of developement of sufficient block distribution)
PR interval
difference in milliseconds of PR interval (as a mean from all measured leads) between baseline ECG \[T0\] and ECG after confirmation of sufficient area of sensory block \[T1\]
Time frame: from 6 up to 15 minutes (according to time of developement of sufficient block distribution)
PR minimal interval
difference in milliseconds of PR minimal interval (from all measured leads) between baseline ECG \[T0\] and ECG after confirmation of sufficient area of sensory block \[T1\]
Time frame: from 6 up to 15 minutes (according to time of developement of sufficient block distribution)
PR maximal interval
difference in milliseconds of PR maximal interval (from all measured leads) between baseline ECG \[T0\] and ECG after confirmation of sufficient area of sensory block \[T1\]
Time frame: from 6 up to 15 minutes (according to time of developement of sufficient block distribution)
P wave dispersion
difference in milliseconds of P wave dispersion (calculated as a difference between the longest and shortest P wave time from all measured leads) between baseline ECG \[T0\] and ECG after confirmation of sufficient area of sensory block \[T1\]
Time frame: from 6 up to 15 minutes (according to time of developement of sufficient block distribution)
P wave index
difference of standard deviations from P wave durations (from all measured leads) between baseline ECG \[T0\] and ECG after confirmation of sufficient area of sensory block \[T1\]
Time frame: from 6 up to 15 minutes (according to time of developement of sufficient block distribution)
PR interval dispersion
difference in milliseconds of PR interval dispersion (calculated as a difference between the longest and shortest PR interval from all measured leads) between baseline ECG \[T0\] and ECG after confirmation of sufficient area of sensory block \[T1\]
Time frame: from 6 up to 15 minutes (according to time of developement of sufficient block distribution)
Plan to share: Undecided
No publications or documents are linked to this record.
This study is completed, as verified in Apr 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Medical University of Gdansk